Robert Z. Gussin's most recent trade in Cassava Sciences Inc was a trade of 26,500 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 23, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cassava Sciences Inc | Robert Z. Gussin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2025 | 26,500 | 26,500 | - | - | Stock Option (Right to Buy) | |
| Cassava Sciences Inc | Robert Z. Gussin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2024 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Cassava Sciences Inc | Robert Z. Gussin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 20,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Cassava Sciences Inc | Robert Z. Gussin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 May 2023 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Cassava Sciences Inc | Robert Z. Gussin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 23.34 per share. | 01 May 2023 | 7,077 | 10,617 (0%) | 0% | 23.3 | 165,177 | Common Stock |
| Cassava Sciences Inc | Robert Z. Gussin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.60 per share. | 01 May 2023 | 3,571 | 17,694 (0%) | 0% | 19.6 | 69,992 | Common Stock |
| Cassava Sciences Inc | Robert Z. Gussin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.66 per share. | 01 May 2023 | 3,571 | 14,123 (0%) | 0% | 16.7 | 59,493 | Common Stock |
| Cassava Sciences Inc | Robert Z. Gussin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 3,571 | 0 | - | - | Stock Option (Right to Buy) | |
| Cassava Sciences Inc | Robert Z. Gussin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 3,571 | 0 | - | - | Stock Option (Right to Buy) | |
| Cassava Sciences Inc | Robert Z. Gussin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.66 per share. | 01 May 2023 | 2,142 | 10,552 (0%) | 0% | 16.7 | 35,686 | Common Stock |
| Cassava Sciences Inc | Robert Z. Gussin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 2,142 | 0 | - | - | Stock Option (Right to Buy) | |
| Cassava Sciences Inc | Robert Z. Gussin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.30 per share. | 29 Mar 2022 | 4,669 | 9,633 (0%) | 0% | 20.3 | 94,781 | Common Stock |
| Cassava Sciences Inc | Robert Z. Gussin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2022 | 4,669 | 0 | - | - | Common Stock | |
| Cassava Sciences Inc | Robert Z. Gussin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.98 per share. | 29 Mar 2022 | 4,024 | 8,410 (0%) | 0% | 40.0 | 160,880 | Common Stock |
| Cassava Sciences Inc | Robert Z. Gussin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.59 per share. | 29 Mar 2022 | 2,801 | 12,434 (0%) | 0% | 23.6 | 66,076 | Common Stock |
| Cassava Sciences Inc | Robert Z. Gussin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Mar 2022 | 2,801 | 0 | - | - | Common Stock | |
| Cassava Sciences Inc | Robert Z. Gussin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Sep 2021 | 2,801 | 0 | - | - | Common Stock | |
| Cassava Sciences Inc | Robert Z. Gussin | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 27.37 per share. | 15 Sep 2021 | 2,801 | 6,710 (0%) | 0% | 27.4 | 76,663 | Common Stock |
| Cassava Sciences Inc | Robert Z. Gussin | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 43.92 per share. | 15 Sep 2021 | 1,746 | 4,964 (0%) | 0% | 43.9 | 76,684 | Common Stock |
| Cassava Sciences Inc | Robert Z. Gussin | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Dec 2020 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) |